Kellerer, C.* et al. COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort. Respir. Med. 185:106461 (2021)
Kahnert, K.* et al. Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET. Respir. Med. 172:106117 (2020)
Kirchberger, I. et al. The lived experience with pulmonary embolism: A qualitative study using focus groups. Respir. Med. 167:105978 (2020)
Kirsch, F. et al. Effect of BMI on health care expenditures stratified by COPD GOLD severity grades: Results from the LQ-DMP study. Respir. Med. 175:106194 (2020)
Lutter, J. et al. Utilization and determinants of use of non-pharmacological interventions in COPD: Results of the COSYCONET cohort. Respir. Med. 171:106087 (2020)
Carsin, A.E.* et al. Restrictive spirometry pattern is associated with low physical activity levels. A population based international study. Respir. Med. 146, 116-123 (2019)
Frank, A.L. ; Kreuter, M.* & Schwarzkopf, L. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care. Respir. Med. 152, 25-31 (2019)
Marietta von Siemens, S.* et al. CAT score single item analysis in patients with COPD: Results from COSYCONET. Respir. Med. 159:105810 (2019)
Alter, P.* et al. Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling. Respir. Med. 137, 14-22 (2018)
Kahnert, K.* et al. The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir. Med. 134, 79-85 (2018)
Matthes, S.* et al. Asthma features in severe COPD: Identifying treatable traits. Respir. Med. 145, 89-94 (2018)
Karch, A.* et al. The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. Respir. Med. 114, 27-37 (2016)
Schwarzkopf, L. et al. Impact of chronic ischemic heart disease on the health care costs of COPD patients – An analysis of German claims data. Respir. Med. 118, 112-118 (2016)
Wacker, M. et al. Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study. Respir. Med. 111, 39-46 (2016)
Burns, J.* et al. Asthma prevalence in Olympic summer athletes and the general population: An analysis of three European countries. Respir. Med. 109, 813-820 (2015)
Rottenkolber, M.* et al. Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients. Respir. Med. 108, 1075-1090 (2014)
Menn, P. et al. Direct medical costs of COPD - an excess cost approach based on two population-based studies. Respir. Med. 106, 540-548 (2012)
Karrasch, S.* et al. Exhaled nitric oxide and influencing factors in a random population sample. Respir. Med. 105, 713-718 (2011)
Koch, B.* et al. Lung function reference values in different German populations. Respir. Med. 105, 352-362 (2011)
Meyer, T.* et al. Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD. Respir. Med. 105, 900-906 (2011)
Schnabel, E. ; Nowak, D.* ; Brasche, S.* ; Wichmann, H.-E. & Heinrich, J. Association between lung function, hypertension and blood pressure medication. Respir. Med. 105, 727-733 (2011)
Karrasch, S. ; Holz, C.* & Jörres, R.A.* Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir. Med. 102, 1215-1230 (2008)
Sausenthaler, S. ; Kompauer, I. ; Brasche, S.* ; Linseisen, J.* & Heinrich, J. Sodium intake and bronchial hyperresponsiveness in adults. Respir. Med. 99, 864-870 (2005)
Lenz, A.-G. et al. Influence of inflammatory mechanisms on the redox balance in interstitial lung diseases. Respir. Med. 98, 737-745 (2004)
Mueller, J.E. ; Frye, C. ; Brasche, S.* & Heinrich, J. Association of hormone replacement therapy with bronchial hyper-responsiveness.  Respir. Med. 97, 990-992 (2003)
Richter, K.* ; Heinrich, J. ; Jörres, R.A.* ; Magnussen, H.* & Wichmann, H.-E. Trends in bronchial hyperresponsiveness, respiratory symptoms and lung function among adults: West and East West Germany. Respir. Med. 94, 668-677 (2000)